Serum amyloid a protein is a useful inflammatory marker during late-onset sepsis in preterm infants

Biology of the Neonate

Volumn 87, Issue 2, 2005, Pages 105-110

  Arnon, Shmuel ^a   Litmanovitz, Ita ^a   Regev, Rivka ^a   Bauer, Sofia ^a   Lis, Monica ^a,b   Shainkin Kestenbaum, Ruth ^a,b   Dolfin, Tzipora ^a  

^a MEIR MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

C reactive protein; Interleukin 6; Preterm infants, sepsis; Serum amyloid A in sepsis

Indexed keywords

ACUTE PHASE PROTEIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERLEUKIN 6; SERUM AMYLOID A;

ARTICLE; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE COURSE; FEMALE; HUMAN; INFANT; INFLAMMATION; MALE; NEWBORN; ONSET AGE; PREDICTION; PREMATURITY; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SEPSIS;

ACUTE-PHASE PROTEINS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; INFLAMMATION; INTERLEUKIN-6; MALE; SEPSIS; SERUM AMYLOID A PROTEIN; TIME FACTORS;

EID: 14044279828     PISSN: 00063126     EISSN: None     Source Type: Journal    
DOI: 10.1159/000081979     Document Type: Article

References (14)

1. Fanaroff AA, Korones SB, Wright LL, Verter J, Poland RL, Bauer CR, Tyson JE, Philips JB 3rd, Edwards W, Lucey JF, Catz CS, Shankaran S, Oh W: Incidence, presenting features and risk factors and significance of late-onset septicemia in very low birth weight infants. The National Institute of Child Health and Human Development Neonatal Research Network. Pediatr Infect Dis J 1998;17:593-598.
2. Gerdes JS: Clinicopathologic approach to the diagnosis of neonatal sepsis. Clin Perinatol 1991;18:361-381.
3. Bomela HN, Ballot DE, Cory BJ, Cooper PA: Use of C-reactive protein to guide duration of empiric antibiotic therapy in suspected early neonatal sepsis. Pediatr Infect Dis J 2000;19:531-535.
4. Ehl S, Gering B, Bartmann P, Hogel J, Pohlandt F: C-reactive protein is a useful marker for guiding duration of antibiotic therapy in suspected neonatal bacterial infection. Pediatrics 1997;99:216-221.
5. Gabay C, Kushner I: Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999;340:448-454.
6. Mozes G, Fridman N, Shainkin-Kestenbaum R: Serum amyloid A: An extremely sensitive marker for intensity of tissue damage in trauma patients and indicator of acute response in various diseases. J Trauma 1989;29:71-74.
7. Pizzini C, Mussap M, Plebani M, Fanos V: C-reactive protein and serum amyloid A protein in neonatal infections. Scand J Infect Dis 2000;32:229-235.
8. Arnon S, Litmanovitz I, Regev R, Lis M, Shainkin-Kestenbaum R, Dolfin T: Serum amyloid A protein in the early detection of late-onset bacterial sepsis in preterm infants. J Perinat Med 2002;30:329-332.
9. Arnon S, Litmanovitz I, Regev R, Lis M, Shainkin-Kestenbaum R, Dolfin T: The prognostic virtue of inflammatory markers during late-onset sepsis in preterm infants. J Perinat Med 2004;32:176-180.
10. Ng PC, Cheng SH, Chui KM, Fok TF, Wong MY, Wong W, Wong RP, Cheung KL: Diagnosis of late onset neonatal sepsis with cytokines, adhesion molecule, and C-reactive protein in preterm very low birthweight infants. Arch Dis Child Fetal Neonatal Ed 1997;77:F221-227.
11. Mehr S, Doyle LW: Cytokines as markers of bacterial sepsis in newborn infants: A review. Pediatr Infect Dis J 2000;19:879-887.
12. Franz AR, Steinbach G, Kron M, Pohlandt F: Reduction of unnecessary antibiotic therapy in newborn infants' interleukin-8 and C-reactive protein as markers of bacterial infection. Pediatrics 1999;1044:47-53.
13. Ray BK, Ray A: Involvement of an SAF-like transcription factor in the activation of serum amyloid A gene in monocyte/macrophage cells by lipopolysaccharide. Biochemistry 1997;36(15):4662-4668.
14. Wada A, Yamada T, Itoh Y, Itoh K: Sensitive enzyme-linked immunosorbent assay for human serum amyloid A (SAA) and application to clearance study (in Japanese). Rinsho Byori 1998;46:1252-1257.